Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer's Chantix Warning May Remain As FDA Raises Trial Concerns

Sep 12 2016

• By Derrick Gingery

Related Content

FDA’s Black Box Instant Replay: A Higher Standard To Remove

Oct 20 2014

Pfizer’s Effort To Remove Chantix Boxed Warning May Backfire

Oct 17 2014

FDA Reviewing Chantix Postmarketing Data On Suicide, Erratic Behavior

Nov 20 2007

Related Companies

Pfizer Inc.

GSK plc

Additional Topics

United States Advisory Committees Drug Review Regulation BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window